4.7 Article

Human umbilical cord mesenchymal stem cell-derived exosomal miR-335-5p attenuates the inflammation and tubular epithelial-myofibroblast transdifferentiation of renal tubular epithelial cells by reducing ADAM19 protein levels

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy

Behnoush Sohrabi et al.

Summary: Mesenchymal stem cells (MSCs) have potential in cancer therapy and can be used as vehicles in cancer gene therapy. MSC-derived exosomes, as novel cell-free alternatives to MSC-based cell therapy, have advantages in safety, stability, and convenience. Unmodified MSC-derived exosomes can promote or inhibit tumors, while modified exosomes can suppress cancer development by delivering therapeutic molecules.

CANCER GENE THERAPY (2022)

Review Pharmacology & Pharmacy

Therapeutic and delivery strategies of phytoconstituents for renal fibrosis

Huan Xu et al.

Summary: CKD is a common disease endangering human health and life, with RF being an important intermediate link in the progression of CKD. Active phytoconstituents extracted from various plants have potential therapeutic capabilities in RF treatment and can be structurally modified or combined with other ingredients to enhance efficiency and reduce toxicity. Delivery strategies of phytoconstituents can overcome renal barriers, improve bioavailability, and targeting in RF treatment.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Biochemistry & Molecular Biology

Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control

Yu-Shui Ma et al.

Summary: Exosomes, derived from the nuclear endosome and plasma membrane, are effective carriers of intercellular signals, efficiently transferring proteins, lipids, and nucleic acids between cells. They have stable biological characteristics, diverse contents, non-invasive signaling molecule introduction pathways, and rapid detection capabilities, making them promising clinical diagnostic markers for various pathological conditions.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Genetics & Heredity

Construction and Analysis of a ceRNA Network in Cardiac Fibroblast During Fibrosis Based on in vivo and in vitro Data

Qing-Yuan Gao et al.

Summary: In this study, a cardiac fibroblast-specific ceRNA network, including two lncRNA, three miRNA, and two mRNA, was identified to play a crucial role in cardiac fibrosis.

FRONTIERS IN GENETICS (2021)

Article Biochemistry & Molecular Biology

MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2

Xiangnan Dong et al.

Summary: The study demonstrated that miR-363-3p plays a protective role in renal fibrosis by regulating the TGF-beta 2/Smad3 signaling pathway. The decreased expression of miR-363-3p in TGF-beta 1-treated HK-2 cells led to increased levels of fibrotic markers, which were reversed by miR-363-3p mimics but suppressed by TGF-beta 2-plasmid. These findings provide new insights into the molecular mechanisms underlying renal fibrosis.

BIOCHEMICAL GENETICS (2021)

Review Physiology

Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis

Yue-Yu Gu et al.

Summary: Renal fibrosis is a key pathological feature of CKD, and TGF-β and lncRNAs play important roles in fibrosis and inflammation processes, potentially serving as therapeutic targets and biomarkers.

FRONTIERS IN PHYSIOLOGY (2021)

Review Cell & Tissue Engineering

Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis

Yiping Liu et al.

Summary: Renal fibrosis commonly leads to kidney disease, with stem cell therapy showing promising effects in improving kidney function and reducing renal fibrosis. However, further clinical studies are needed to validate these findings.

STEM CELL RESEARCH & THERAPY (2021)

Review Immunology

The Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis

Ryuichi Nagashima et al.

Summary: ILC2s are a recently discovered lymphocyte population with high cytokine productive capacity, especially important in combating helminth infections and allergic tissue inflammation. The cytokine IL-33, released upon tissue damage, may play a role in kidney diseases and fibrosis. Further research is needed to understand the precise contributions of ILC2s to kidney fibrosis and disease progression.

FRONTIERS IN IMMUNOLOGY (2021)

Review Chemistry, Multidisciplinary

Exosome-mediated delivery of gene vectors for gene therapy

Li Duan et al.

Summary: Gene vectors deliver genetic materials or gene editing devices into cells for therapeutic protein production or gene correction, but barriers like cell membrane and degradation necessitate carriers for clinical gene therapy. Exosomes, engineered to encapsulate and deliver nucleic acids, and their fusion with liposomes increase loading capacity and maintain targeting capability, showing promise for future gene delivery applications in therapy.

NANOSCALE (2021)

Article Biochemistry & Molecular Biology

MiR-9-5p protects from kidney fibrosis by metabolic reprogramming

Marta Fierro-Fernandez et al.

FASEB JOURNAL (2020)

Article Medicine, Research & Experimental

Inhibition of miRNA-135a-5p ameliorates TGF-β1-induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy

Juan Zhang et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Review Cell Biology

Evolution, kidney development, and chronic kidney disease

Robert L. Chevalier

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Stem Cell Therapies in Kidney Diseases: Progress and Challenges

Cinzia Rota et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Dentistry, Oral Surgery & Medicine

Antifibrotic Potential of MiR-335-3p in Hereditary Gingival Fibromatosis

Q. Gao et al.

JOURNAL OF DENTAL RESEARCH (2019)

Review Biochemistry & Molecular Biology

Anti-fibrotic treatments: A review of clinical evidence

Marco Allinovi et al.

MATRIX BIOLOGY (2018)

Article Medicine, Research & Experimental

Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro

Hong Huang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Review Physiology

TGF-β/Smad signaling in renal fibrosis

Xiao-Ming Meng et al.

FRONTIERS IN PHYSIOLOGY (2015)

Article Medicine, Research & Experimental

Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury

Xiujuan Peng et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2013)

Editorial Material Cell & Tissue Engineering

Regenerating the injured kidney with human umbilical cord mesenchymal stem cell-derived exosomes

Akaitz Dorronsoro et al.

STEM CELL RESEARCH & THERAPY (2013)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease

Stefania Cannito et al.

ANTIOXIDANTS & REDOX SIGNALING (2010)

Article Respiratory System

Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells

Dominic T. Keating et al.

RESPIRATORY RESEARCH (2006)

Article Surgery

Upregulation of ADAM19 in chronic allograft nephropathy

W. B. W. H. Melenhorst et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2006)